MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 188 filers reported holding MEDIVATION INC in Q2 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $26,958,000 | +128.6% | 447,053 | +74.3% | 0.01% | +133.3% |
| Q1 2016 | $11,791,000 | -17.8% | 256,429 | -13.6% | 0.00% | -25.0% |
| Q4 2015 | $14,345,000 | +24.0% | 296,757 | +9.1% | 0.00% | +33.3% |
| Q3 2015 | $11,565,000 | -4.6% | 272,129 | +156.2% | 0.00% | 0.0% |
| Q2 2015 | $12,126,000 | -15.3% | 106,198 | -4.2% | 0.00% | 0.0% |
| Q1 2015 | $14,308,000 | +68.0% | 110,858 | +29.6% | 0.00% | +50.0% |
| Q4 2014 | $8,519,000 | +18.1% | 85,525 | +17.2% | 0.00% | 0.0% |
| Q3 2014 | $7,213,000 | +44.7% | 72,955 | +12.8% | 0.00% | +100.0% |
| Q2 2014 | $4,986,000 | -55.6% | 64,683 | -62.9% | 0.00% | -66.7% |
| Q1 2014 | $11,229,000 | +2.5% | 174,449 | +1.7% | 0.00% | 0.0% |
| Q4 2013 | $10,950,000 | +33.9% | 171,579 | +25.8% | 0.00% | +50.0% |
| Q3 2013 | $8,176,000 | +45.6% | 136,404 | +19.5% | 0.00% | 0.0% |
| Q2 2013 | $5,617,000 | – | 114,171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |